Suketu Upadhyay Net Worth

The estimated Net Worth of Suketu Upadhyay is at least $8.47 Milione dollars as of 6 March 2024. Mr. Upadhyay owns over 4,561 units of Zimmer Biomet Inc stock worth over $2,385,117 and over the last 12 years he sold ZBH stock worth over $0. In addition, he makes $6,080,250 as Chief Financial Officer e Executive Vice President at Zimmer Biomet Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Upadhyay ZBH stock SEC Form 4 insiders trading

Suketu has made over 9 trades of the Zimmer Biomet Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 4,561 units of ZBH stock worth $479,589 on 6 March 2024.

The largest trade he's ever made was exercising 7,043 units of Zimmer Biomet Inc stock on 25 February 2024 worth over $740,571. On average, Suketu trades about 1,131 units every 100 days since 2012. As of 6 March 2024 he still owns at least 22,683 units of Zimmer Biomet Inc stock.

You can see the complete history of Mr. Upadhyay stock trades at the bottom of the page.

Suketu Upadhyay biography

Suketu P. Upadhyay is appointed as Chief Financial Officer, Executive Vice President of the Company. Prior to joining Zimmer Biomet, Mr. Upadhyay served as Senior Vice President, Global Financial Operations at Bristol-Myers Squibb from November 2016 until June 2019. Before joining Bristol-Myers Squibb, he served as Executive Vice President and Chief Financial Officer of Endo International from September 2013 to November 2016. Prior to his tenure at Endo International, Mr. Upadhyay served as Interim Chief Financial Officer as well as Senior Vice President of Finance, Corporate Controller and Principal Accounting Officer of BD. Prior to his role as BD’s Interim Chief Financial Officer and Corporate Controller, Mr. Upadhyay was the Senior Vice President of Global Financial Planning and Analysis and also held the role of Vice President and Chief Financial Officer of BD’s international business. Before joining BD in 2010, Mr. Upadhyay held a number of leadership roles across AstraZeneca and Johnson & Johnson.

What is the salary of Suketu Upadhyay?

As the Chief Financial Officer e Executive Vice President of Zimmer Biomet Inc, the total compensation of Suketu Upadhyay at Zimmer Biomet Inc is $6,080,250. There are 1 executives at Zimmer Biomet Inc getting paid more, with Bryan Hanson having the highest compensation of $11,176,700.

How old is Suketu Upadhyay?

Suketu Upadhyay is 50, he's been the Chief Financial Officer e Executive Vice President of Zimmer Biomet Inc since 2019. There are 16 older and 6 younger executives at Zimmer Biomet Inc. The oldest executive at Zimmer Biomet Holdings Inc is Larry Glasscock, 72, who is the Independent Non-Executive Chairman of the Board.

What's Suketu Upadhyay's mailing address?

Suketu's mailing address filed with the SEC is 345, East Main Street, Warsaw, Kosciusko County, Indiana, 46580, United States.

Insiders trading at Zimmer Biomet Inc

Over the last 9 years, insiders at Zimmer Biomet Inc have traded over $2,148,754,462 worth of Zimmer Biomet Inc stock and bought 59,988 units worth $7,136,091 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Michael W Michelson e Group Inc Blackstone Group .... On average, Zimmer Biomet Inc executives and independent directors trade stock every 19 days with the average trade being worth of $14,226,269. The most recent stock trade was executed by Zuilen Wilfred Van on 1 July 2024, trading 2,633 units of ZBH stock currently worth $276,860.

What does Zimmer Biomet Inc do?

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.

Complete history of Mr. Upadhyay stock trades at Endo International plc, Vertex Pharmaceuticals, Becton Dickinson & Co e Zimmer Biomet Inc

Zimmer Biomet Inc executives and stock owners

Zimmer Biomet Inc executives and other stock owners filed with the SEC include:

• Bryan Hanson,
  President, Chief Executive Officer, Director
• Suketu Upadhyay,
  Chief Financial Officer, Executive Vice President
• Ivan Tornos,
  Group President - Global Businesses and Americas
• Didier Deltort,
  President - Europe, Middle East and Africa
• Bryan C. Hanson,
  Chairman, Pres & CEO
• Chad Phipps,
  Senior Vice President, General Counsel, Secretary
• Sang Yi,
  President, Asia Pacific
• Ivan Tornos,
  Group Pres of Global Bus.es, The Americas & EMEA Region and COO
• Suketu P. Upadhyay,
  Exec. VP & CFO
• Sang Yi,
  Group Pres of Asia Pacific
• Larry Glasscock,
  Independent Non-Executive Chairman of the Board
• Robert Hagemann,
  Independent Director
• Arthur Higgins,
  Independent Director
• Betsy Bernard,
  Independent Director
• Christopher Begley,
  Independent Director
• Gail Boudreaux,
  Independent Director
• Michael Farrell,
  Independent Director
• Michael Michelson,
  Independent Director
• Maria Hilado,
  Independent Director
• Syed Jafry,
  Independent Director
• Carrie Nichol,
  Chief Accounting Officer, Vice President, Controller
• Keri Mattox,
  Senior Vice President - Investor Relations, Chief Communications Officer
• Angela Main,
  Sr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific
• Chad F. Phipps,
  Sr. VP, Gen. Counsel & Sec.
• Zeeshan Tariq,
  Sr. VP & Chief Information Officer
• Dr. Nitin Goyal M.D.,
  Chief Science, Technology & Innovation Officer
• Derek M. Davis,
  Interim Controller, Chief Accounting Officer, & Principal Accounting Officer
• Louis Shapiro,
  Director
• David C Dvorak,
  President and CEO
• Paul Bisaro,
  Director
• David A. Jr. Nolan,
  Group President
• Adam Rudolph Johnson,
  Group President
• Cecil B Pickett,
  Director
• Katarzyna Mazur Hofsaess,
  Pres., Eur., M. East & Afr.
• Robert D. Delp,
  President, Americas
• Tony W. Collins,
  VP, Controller and CAO
• Jeffrey K. Rhodes,
  Director
• Daniel E. Williamson,
  Group President
• Zuilen Wilfred Van,
  Group Pres, EMEA
• Rachel Ellingson,
  SVP & Chief Strategy Officer
• Aure Bruneau,
  Group President
• Daniel P Florin,
  Exec. VP, CFO
• Sachs Group Incgoldman Sach...,
  
• Stuart G. Kleopfer,
  President, Americas
• Equity Partners 2004 Direct...,
  
• Group Holdings (Sbs) Adviso...,
  
• Group Inc Blackstone Group ...,
  
• Group L.P.Blackstone Manage...,
  
• Capital Partners V L P Blac...,
  
• Acquisition Holding, Llc Lvb,
  
• Sreelakshmi Kolli,
  Director
• Lori Winkler,
  SVP and CHRO
• Devdatt Kurdikar,
  Director
• Derek M Davis,
  Interim Controller & CAO
• Paul A Stellato,
  VP, Controller & CAO
• Mark Bezjak,
  President, Americas